PRNews

LBB Specialties and Clariant Partner to Distribute High-Quality Pharmaceutical Grade PEGs for Ophthalmic Applications

Cision | Thu, Dec 05 2024 07:02 AM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

NORWALK, Conn., Dec. 5, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, announced a strategic partnership with Clariant, a global leader in specialty chemical manufacturing. Through this collaboration, LBB Specialties will distribute Clariant's pharmaceutical-grade high-functional excipients – including their polyethylene glycols (PEGs) and VitiPure® portfolio – for ophthalmic applications in the North American Life Sciences market.

This partnership brings together LBB Specialties' established expertise in the ophthalmic market with Clariant's decades-long experience in producing and supplying high-quality PEGs, a critical component in many ophthalmic formulations.

Clariant's pharmaceutical-grade PEGs, now part of LBB Specialties' innovative Life Sciences portfolio, ensure customers have access to high-performance ingredients designed for various ophthalmic products. From eye drops to gels, the addition of these PEGs strengthens LBB Specialties' ability to meet the evolving demands of the pharmaceutical industry.

"At LBB Specialties, we're committed to providing our customers with the highest quality specialty pharmaceutical ingredients," said Seth Burns, Senior Vice President of Life Sciences at LBB Specialties. "Partnering with Clariant allows us to deliver industry-leading PEGs that offer consistency and performance for ophthalmic applications, providing our customers with the assurance they need throughout the pharmaceutical lifecycle—from R&D to commercialization."

"This partnership with LBB Specialties marks a significant step in our commitment to serving the pharmaceutical industry," said Vaios Barlas, Head of Health Care at Clariant. "Our focus on developing high-performance, pharmaceutical-grade excipients has consistently pushed the boundaries of what's possible in ophthalmic formulations. By leveraging LBB Specialties' strong distribution network in North America, we can ensure that more formulators and manufacturers can access our cutting-edge ingredients, ultimately driving innovation in ophthalmic applications."

To learn more about Clariant's PEGs and how they can benefit your products, contact LBB Specialties today.

About LBB Specialties 
LBB Specialties is a leader in North American specialty chemicals and ingredients distribution. It is a diversified supplier serving end markets including care, food & nutrition, industrial specialties, and life sciences. www.LBBSpecialties.com.

About Clariant
Clariant is a focused specialty chemical company led by the overarching purpose of "Greater chemistry – between people and planet." By connecting customer focus, innovation, and people, the company creates solutions to foster sustainability in different industries. On December 31, 2023, Clariant totaled a staff number of 10,481 and recorded sales of CHF 4.377 billion in the fiscal year for its continuing businesses. Since January 2023, the Group conducts its business through the three Business Units: Care Chemicals, Catalysts, and Adsorbents & Additives. Clariant is based in Switzerland.

Clariant Health Care is a leading high-quality solution partner for the global pharmaceutical industry, with a strong portfolio of top-performing excipients and active pharmaceutical ingredients (APIs), backed by operational excellence and years of experience in regulatory affairs. https://www.clariant.com/HealthCare

Media Contact:
Ahmed Hanafy
media@lbbspecialties.com

PRNews

CJ 4DPLEX Appoints Jun Bang as New CEO

Bang is the youngest ever CEO to be appointed within the CJ Group of Companies SEOUL, South Korea and HOLLYWOOD, ...

Cision | Thu, Dec 05 2024 01:32 PM AEDT

Read More
PRNews

Relaxation, Family Travel, and Exploring New Destinations to Define Travel Next Year - Agoda Shares Seven Travel Trends for 2025

SINGAPORE, Dec. 5, 2024 /PRNewswire/ -- Digital travel platform Agoda has unveiled its 2025 Travel Trends survey, highlighting the key factors set ...

Cision | Thu, Dec 05 2024 01:05 PM AEDT

Read More
PRNews

Binance Becomes the Official Gold Sponsor of Taipei Blockchain Week 2024

TAIPEI, Dec. 5, 2024 /PRNewswire/ -- Binance, the global blockchain ecosystem behind the largest cryptocurrency exchange by trading volume, is delighted to ...

Cision | Thu, Dec 05 2024 01:00 PM AEDT

Read More
PRNews

AI-Powered Application Development Introduces New IT Challenges, According to OutSystems Study

While 88% of IT professionals are exploring building GenAI-powered apps, security and governance concerns and talent shortages are stalling projects  ...

Cision | Thu, Dec 05 2024 01:00 PM AEDT

Read More
PRNews

Xinhua Silk Road: Annual analysis report on taro price index released at the 2024 Boao Forum for Entrepreneurs

BEIJING, Dec. 5, 2024 /PRNewswire/ -- The annual analysis report on the taro price index was released during the 2024 Entrepreneurs Boao ...

Cision | Thu, Dec 05 2024 12:54 PM AEDT

Read More